CSIMarket
 


Precipio inc   (PRPO)
Other Ticker:  
 
 

PRPO's Revenue Growth by Quarter and Year

Precipio Inc 's Revenue results by quarter and year




PRPO Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 2.44 1.94 0.69
III Quarter September 2.22 2.25 1.63 0.78
II Quarter June 2.36 2.34 1.31 0.94
I Quarter March 2.45 1.82 1.22 0.71
FY   7.03 8.85 6.10 3.12



PRPO Revenue third quarter 2022 Y/Y Growth Comment
Precipio Inc reported decrease in Revenue in the third quarter 2022 by -1.56% to $ 2.22 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 Precipio Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.6%.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 76 other companies have achieved higher Revenue growth. While Precipio Inc ' s Revenue decline of -1.56% ranks overall at the positon no. 2091 in the third quarter 2022.




PRPO Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 25.77 % 181.16 % -54.3 %
III Quarter September -1.56 % 38.04 % 108.97 % 9.86 %
II Quarter June 0.85 % 78.63 % 39.36 % 123.81 %
I Quarter March 34.62 % 49.18 % 71.83 % 115.15 %
FY   - 45.08 % 95.51 % 5.05 %

Financial Statements
Precipio Inc 's third quarter 2022 Revenue $ 2.22 millions PRPO's Income Statement
Precipio Inc 's third quarter 2021 Revenue $ 2.25 millions Quarterly PRPO's Income Statement
New: More PRPO's historic Revenue Growth >>


PRPO Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 8.44 % 19.02 % -11.54 %
III Quarter September -6.14 % -3.85 % 24.43 % -17.02 %
II Quarter June -3.67 % 28.57 % 7.38 % 32.39 %
I Quarter March 0.41 % -6.19 % 76.81 % -52.98 %
FY (Year on Year)   - 45.08 % 95.51 % 5.05 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #77
Healthcare Sector #318
Overall #2091

Revenue Y/Y Growth Statistics
High Average Low
67.14 % 3.6 % -93.44 %
(Dec 31 2018)   (Dec 31 2015)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #77
Healthcare Sector #318
Overall #2091
Revenue Y/Y Growth Statistics
High Average Low
67.14 % 3.6 % -93.44 %
(Dec 31 2018)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Precipio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
113.98 % 7.41 % -52.75 %
(Jun 30 2016)  


PRPO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Precipio Inc reported decline in Revenue from the previous quarter by -6.14% to $ 2.22 millions, from $ 2.36 millions released a quarter before.

But that's not important concern, as Precipio Inc 's Revenue always gravitate to dip in this quarter Melissa Miller, Healthcare sector researcher told.

Within Biotechnology & Pharmaceuticals industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2258.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #85
Healthcare Sector #369
Overall #2258
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #85
Healthcare Sector #369
Overall #2258
Revenue Q/Q Growth Statistics
High Average Low
113.98 % 7.41 % -52.75 %
(Jun 30 2016)  


PRPO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Precipio Inc reported decline in Revenue from the previous quarter by -6.14% to $ 2.22 millions, from $ 2.36 millions achived a quarter before.

It's not huge concern, as Revenue frequently gravitate to dip in this quarter Melissa Miller, Healthcare sector researcher told.

Within Biotechnology & Pharmaceuticals industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2258.


Precipio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 9.46 $ 9.49 $ 9.47 $ 8.85 $ 8.36
Y / Y Revenue Growth (TTM) 13.18 % 22.63 % 41.37 % 45.26 % 72.66 %
Year on Year Revenue Growth Overall Ranking # 1239 # 973 # 670 # 647 # 417
Seqeuential Revenue Change (TTM) -0.33 % 0.16 % 7.04 % 5.91 % 8 %
Seq. Revenue Growth (TTM) Overall Ranking # 2091 # 2163 # 743 # 1275 # 1086




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Precipio Inc 's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of 8% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Precipio Inc 's Revenue growth from the 2.36% growth in Jun 30 2022.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 973 to 1239.

Revenue TTM Q/Q Growth Statistics
High Average Low
67.14 %
3.6 %
-93.44 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 77
Healthcare Sector # 193
Overall # 1239

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
27.76 %
-93.9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 77
Sector # 318
S&P 500 # 2091
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Precipio Inc 's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of -93.9% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Precipio Inc 's Revenue growth from the 2.36% growth in Jun 30 2022.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 973 to 1239.

Revenue TTM Q/Q Growth Statistics
High Average Low
67.14 %
3.6 %
-93.44 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 77
Healthcare Sector # 193
Overall # 1239

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
27.76 %
-93.9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 77
Sector # 318
S&P 500 # 2091




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRPO's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PRPO's Competitors
Revenue Growth for Precipio Inc 's Suppliers
Revenue Growth for PRPO's Customers

You may also want to know
PRPO's Annual Growth Rates PRPO's Profitability Ratios PRPO's Asset Turnover Ratio PRPO's Dividend Growth
PRPO's Roe PRPO's Valuation Ratios PRPO's Financial Strength Ratios PRPO's Dividend Payout Ratio
PRPO's Roa PRPO's Inventory Turnover Ratio PRPO's Growth Rates PRPO's Dividend Comparisons



Companies with similar Revenue decline for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADMEN's Profile

Stock Price

ADMEN's Financials

Business Description

Fundamentals

Charts & Quotes

ADMEN's News

Suppliers

ADMEN's Competitors

Customers & Markets

Economic Indicators

ADMEN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071